Abstract
This article provides guidelines on the treatment of nicotine dependence and tobacco addiction that are based on the recent US Agency for Health Care Policy and Research (AHCPR) Smoking Cessation Clinical Practice Guideline. Nicotine replacement therapy should be encouraged for most patients in the absence of specific contraindications, as it has been shown to be efficacious in increasing abstinence rates in smoking cessation. Although 4 types of nicotine replacement therapy (transdermal patch, polacrilex chewing gum, spray and inhaler) have been shown to be effective, the transdermal nicotine patch is associated with fewer patient compliance problems and/or adverse effects. Clinician-provided social support and skills-training/problem-solving techniques are also effective components of smoking cessation treatment. Smoking cessation interventions of this type that are as brief as 3 minutes are effective in producing both short and long term abstinence, although rates of quitting are higher with more frequent and intensive treatments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.